Skip to main content
Equibles

ALLIANCEBERNSTEIN L.P.

Position in EDIT — Editas Medicine, Inc.

CIK 1109448 NASHVILLE, TN
Back to EDIT Full portfolio

Position in EDIT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$608,893
+$195,094 QoQ
Shares Held
187,930
+12.2% QoQ
Ownership
0.122%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#51
of 216 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in EDIT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ALLIANCEBERNSTEIN L.P. holds $5,185,395,108 across 257 Biotechnology names. EDIT ranks #160 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,019,315 $1,499,784,339
2 ARGX
Argenx SE
 395,661 $367,082,405
3 GMAB
Genmab A/S
 8,644,877 $237,474,771
4 REGN
Regeneron Pharmaceuticals, Inc.
 292,338 $182,284,436
5 TECH
BIO-TECHNE Corp
 2,002,026 $141,443,136
6 HALO
Halozyme Therapeutics, Inc.
 1,696,538 $132,788,029
7 KYMR
Kymera Therapeutics, Inc.
 981,521 $112,551,013
8 BBIO
BridgeBio Pharma, Inc.
 1,453,504 $108,256,977

All Filings in EDIT

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $608,893 187,930
2026-03-31 $413,799 167,530
2025-12-31 $343,436 167,530
2025-09-30 $581,329 167,530
2025-06-30 $404,118 183,690
2025-03-31 $155,010 133,630
2024-12-31 $169,710 133,630
2024-09-30 $459,770 134,830
2024-06-30 $629,656 134,830
2024-03-31 $612,150 82,500
2023-12-31 $835,725 82,500
2023-09-30 $643,500 82,500
2023-06-30 $712,718 86,600
2023-03-31 $598,125 82,500
2022-12-31 $731,775 82,500
2022-09-30 $1,009,800 82,500
2022-06-30 $975,975 82,500
2022-03-31 $1,569,226 82,504
2021-12-31 $2,185,171 82,304
2021-09-30 $3,381,048 82,304
2021-06-30 $4,661,698 82,304
2021-03-31 $3,456,768 82,304
2020-12-31 $5,734,998 81,800
2020-09-30 $2,295,308 81,800
2020-06-30 $2,407,812 81,400
2020-03-31 $1,350,423 68,100